FDA Tells Company To Stop Selling Genetic Test
STEVE INSKEEP, HOST:
A high-profile genetic medical testing company is in trouble with the federal government. The Food and Drug Administration has asked 23 And Me to temporarily halt its work.
As NPR's Rob Stein reports, the FDA has accuracy concerns.
ROB STEIN, BYLINE: 23 And Me may be best known for its $99 genetic test. For $99, anyone can get their DNA analyzed. No need to go to a doctor. No need to get their blood drawn. Just send in a saliva sample and wait to find out all sorts of things: How your body handles caffeine, how certain drugs work for you, and whether you're at risk for all kinds of diseases. And that's where 23 And Me is running into trouble.
Courtney Lias of the FDA says the company has failed to do the studies that prove their medical tests are accurate.
COURTNEY LIAS: They don't have any way of knowing whether or not their test is as accurate as they say that it is because they haven't actually provided the information that either we or they would need to know how accurate the study is.
STEIN: And the FDA says that's a big problem. Customers may make major decisions based on the results. For example, women might resort to drastic measures that are unnecessary if they think they're at risk for breast cancer.
LIAS: Women who find out that they are positive may take steps like surgery or mastectomy in order to avoid breast cancer.
STEIN: So the FDA has ordered 23 And Me to stop selling its medical testing until the company proves it's reliable. The company would only say it will work with the FDA to satisfy the agency's concerns. The FDA says 23 And Me has about two weeks to respond.
Rob Stein, NPR News.
NPR transcripts are created on a rush deadline by a contractor for NPR, and accuracy and availability may vary. This text may not be in its final form and may be updated or revised in the future. Please be aware that the authoritative record of NPR's programming is the audio.